Dapagliflozin Safe and Effective in Elderly Patients with Heart Failure Undergoing Valve Replacement
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
Abstract: To address the issue of excessively high failure rates in civil aircraft bleed air system valves, this study performed fault symptom analysis using flight test data, established a warning ...
Right‐sided heart failure (RHF), in the presence of tricuspid valve regurgitation, results from left‐sided heart failure, pulmonary hypertension (PH), or heart malformations. The occurrence of RHF and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results